Allstate Corp Gilead Sciences, Inc. Transaction History

Allstate Corp

$1.02 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $37,447 - $43,217	-593 Reduced 13.96%	3,656 $250,000
Q1 2024 May 10, 2024	BUY	$71.58 - $87.29 $13,385 - $16,323	187 Added 4.6%	4,249 $311,000
Q4 2023 Feb 09, 2024	BUY	$73.27 - $83.09 $13,408 - $15,205	183 Added 4.72%	4,062 $329,000
Q1 2023 May 10, 2023	SELL	$77.31 - $88.08 $3.3 Million - $3.76 Million	-42,667 Reduced 91.67%	3,879 $321,000
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $46,615 - $66,923	748 Added 1.63%	46,546 $4 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $52,692 - $60,188	-885 Reduced 1.9%	45,798 $2.83 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $1.61 Million - $1.81 Million	27,842 Added 147.77%	46,683 $2.89 Million
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $4.24 Million - $5.32 Million	-73,249 Reduced 79.54%	18,841 $1.12 Million
Q4 2021 Feb 15, 2022	BUY	$64.88 - $73.64 $5.13 Million - $5.82 Million	79,008 Added 603.94%	92,090 $6.69 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $188,381 - $203,242	-2,783 Reduced 17.54%	13,082 $914,000
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $156,897 - $171,433	-2,472 Reduced 13.48%	15,865 $1.09 Million
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $583,380 - $665,636	9,723 Added 112.87%	18,337 $1.19 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $438,980 - $500,197	-7,749 Reduced 47.36%	8,614 $502,000
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $1.23 Million - $1.54 Million	-19,753 Reduced 54.69%	16,363 $1.03 Million
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $214,632 - $249,228	2,967 Added 8.95%	36,116 $2.78 Million
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $1.28 Million - $1.64 Million	20,493 Added 161.92%	33,149 $2.48 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $779,862 - $857,823	12,656 New	12,656 $822,000
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $2.08 Million - $2.29 Million	-33,225 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $1.36 Million - $1.53 Million	-22,035 Reduced 39.88%	33,225 $2.25 Million
Q1 2019 May 20, 2019	BUY	$62.53 - $70.05 $1.93 Million - $2.16 Million	30,873 Added 126.6%	55,260 $3.59 Million
Q4 2018 Feb 13, 2019	BUY	$60.54 - $79.0 $1.48 Million - $1.93 Million	24,387 New	24,387 $1.53 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

News

Stay updated on Allstate Corp with notifications on news.

Account